Earnings calendar/MRNA
Moderna, Inc. (MRNA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-1.38
Street estimate
Revenue target
$872.9M
Street estimate
Trailing EPS (avg 4Q)
$-2.00
Beat rate last 4: 100%
Latest EPS YoY
+7.5%
vs 2025-08-01
Latest revenue YoY
+2.1%
How results look so far
Trailing revenue (avg 4Q)
$557.0M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 31, 2026
EPS beat
EPS actual / est
$-1.97 / $-2.03
+3.0%
Revenue actual / est
$145.0M / $102.9M
+40.9%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-1.38 | Pending | — | $872.9M | Pending | — |
| 7/31/2026 | $-2.03 | $-1.97 | +3.0% | $102.9M | $145.0M | +40.9% |
| 5/7/2026upcoming | $-2.03 | Pending | — | $239.7M | Pending | — |
| 5/1/2026 | $-4.45 | $-3.40 | +23.6% | $236.4M | $389.0M | +64.6% |
| 2/13/2026 | $-2.54 | $-2.11 | +16.9% | $635.2M | $678.0M | +6.7% |
| 11/6/2025 | $-1.87 | $-0.51 | +72.7% | $920.9M | $1.02B | +10.3% |
| 8/1/2025 | $-2.99 | $-2.13 | +28.8% | $893.3M | $142.0M | -84.1% |
| 5/1/2025 | $-2.92 | $-2.52 | +13.7% | $116.7M | $107.0M | -8.3% |
| 2/14/2025 | $-2.68 | $-2.50 | +6.7% | $942.8M | $956.0M | +1.4% |
| 11/7/2024 | $-1.91 | $0.03 | +101.6% | $1.25B | $1.85B | +48.4% |
| 8/1/2024 | $-3.35 | $-3.33 | +0.6% | $128.4M | $241.0M | +87.7% |
| 5/2/2024 | $-3.56 | $-3.07 | +13.8% | $93.3M | $167.0M | +79.1% |
| 2/22/2024 | $-0.97 | $0.55 | +156.7% | $2.51B | $2.81B | +12.0% |
| 11/2/2023 | $-1.93 | $-9.53 | -393.2% | $1.38B | $1.83B | +32.3% |
| 8/3/2023 | $-3.84 | $-3.62 | +5.7% | $319.6M | $344.0M | +7.6% |
| 5/4/2023 | $-1.77 | $0.19 | +110.7% | $1.18B | $1.84B | +56.0% |
| 2/23/2023 | $4.68 | $3.61 | -22.9% | $5.02B | $5.08B | +1.3% |
| 11/3/2022 | $3.29 | $2.53 | -23.1% | $3.53B | $3.22B | -8.7% |
| 8/3/2022 | $4.55 | $5.24 | +15.2% | $4.10B | $4.57B | +11.4% |
| 5/4/2022 | $5.21 | $8.58 | +64.7% | $4.20B | $5.94B | +41.3% |
Need MRNA data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.